US Bancorp
BNR

US Bancorp’s Burning Rock Biotech BNR Stock Holding History

US Bancorp’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-79
Closed -$2K – 4149
2022
Q3 		$2K Sell
79
-79
-50% -$2.55K ﹤0.01% 3803
2022
Q2 		$5K Sell
158
-1,363
-90% -$60.9K ﹤0.01% 3571
2022
Q1 		$142K Buy
1,521
+139
+10% +$12.1K ﹤0.01% 2116
2021
Q4 		$132K Buy
1,382
+251
+22% +$34.4K ﹤0.01% 2160
2021
Q3 		$202K Buy
+1,131
New +$251K ﹤0.01% 1962

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

US Bancorp's BNR Position: Q4 2022 in Review

US Bancorp sold out of Burning Rock Biotech (BNR) in Q4 2022, closing a stake of 79 shares — an estimated $2K sold.

US Bancorp first reported a position in BNR in Q3 2021 and held it in 5 quarters. The position peaked at $202K in Q3 2021. 42 funds tracked by Wall St. Rank hold BNR as of Q4 2022.

  • US Bancorp reported no remaining Burning Rock Biotech position as of Q4 2022 after selling out during the quarter.
  • US Bancorp sold 79 Burning Rock Biotech shares in Q4 2022, an estimated $2K.
  • US Bancorp first reported a position in Burning Rock Biotech in Q3 2021 and held it in 5 quarters.
  • US Bancorp's Burning Rock Biotech position peaked at $202K in Q3 2021.
  • 42 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2022.

Based on US Bancorp's 13F filing for Q4 2022, filed 13 Feb 2023.